Blood blisters all over her feet after AZ vaccination 34-year-old woman nearly had her leg amputated

The Sun reported that Sarah Beuckmann, a 34-year-old Scottish woman, had a suspected severe allergic reaction after receiving the New Coronary Pneumonia (COVID-19) AZ vaccine developed by AstraZeneca in collaboration with Oxford University (OxfordUniversity). The vaccine was administered by AstraZeneca and Oxford University in Oxford, England, and was almost forced to be amputated.

According to reports, after receiving the AZ vaccine, Beekman initially experienced the usual side effects of fatigue, headache and muscle aches, but later began to feel tingling in her feet, and seven days later began to develop a rash, which later “evolved” into a large number of blisters with blood. She therefore sought help from a medical institution.

The AZ vaccine has been widely discussed recently because of its side effects. The picture shows Canadian Prime Minister Justin Trudeau getting the AZ vaccine on the 23rd. (Photo / Associated Press)

It is said that the medical staff has not been exposed to such conditions, and Beekman’s calm heartbeat of more than 160 per minute is very worrying; Beekman said she once considered amputation, because even the medical staff did not know what to do. Fortunately, after the medical staff decided to use steroids on Beekman, her condition improved quickly, but she remained in the hospital for 16 days before being released on April 16.

Even after such a horrific experience, Beekman urged everyone to continue getting vaccinated. She said that while her condition does not allow for a second dose of the AZ vaccine, based on the current status of administration, the vaccine is “safe for most people.

The AZ vaccine has been widely discussed recently because of its side effects. The European Medicines Agency (EMA) Safety Committee and the UK Medicines and Healthcare Products Regulatory Agency (MHRA) have previously confirmed that the AZ vaccine has a “very low probability of developing symptoms of thrombosis and thrombocytopenia” within 2 weeks of administration, with women under the age of 60 being at high risk. While both have reiterated that the benefits of AZ vaccination “outweigh the risks,” many countries, including the United Kingdom, have decided to administer the vaccine only to older age groups with a higher risk of pneumonia in order to ensure a balance of risk.